Product
M72/AS01E-4
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial to Assess the Prophylactic Efficacy, Safety, and Immunogenicity of the Investigational M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine When Administered Intramuscularly on a 0,1-month Schedule to Adolescents and AdultsStatus: Recruiting, Estimated PCD: 2028-04-01